Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Clinical trial NCT06739252 · TERMINATED

Trial details

NCT number: NCT06739252
Sponsor: Peking University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma (Icc)Perihilar Cholangiocarcinoma

Start date: 2024-12-31
Primary completion: 2025-12-22
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.